Ampio Pharmaceuticals, Inc. (18)
Browse by Contract Category
Contracts
-
Amendment No. 3 to Employment Agreement, dated July 13, 2020, between the Company and Daniel Stokely
(Filed With SEC on July 14, 2020)
-
Loan Agreement, dated April 16, 2020, by and between Key Bank National Association and Ampio Pharmaceuticals, Inc
(Filed With SEC on April 22, 2020)
-
Sales Agreement, dated as of February 20, 2020, by and among ThinkEquity, a division of Fordham Financial Management, Inc., Roth Capital Partners LLC and Ampio Pharmaceuticals, Inc
(Filed With SEC on February 20, 2020)
-
Amendment to Cancellation Agreement, dated November 7, 2019, between Ampio Pharmaceuticals Inc. and Daniel Stokely
(Filed With SEC on November 7, 2019)
-
Amendment No. 3 to Human Serum Albumin Ingredient Purchase and Sale Agreement among Ampio Pharmaceuticals, Inc., Octapharma USA, Inc. and Nova Biologics, Inc., effective as of...
(Filed With SEC on February 21, 2020)
-
Description of Capital Stock of Ampio Pharmaceuticals, Inc
(Filed With SEC on February 21, 2020)
-
Amendment No. 2 to Employment Agreement, dated December 14, 2019, between the Company and Daniel Stokely
(Filed With SEC on December 18, 2019)
-
Employment Agreement, dated December 14, 2019, between the Company and Michael Macaluso
(Filed With SEC on December 18, 2019)
-
Form of Warrant Exercise Agreement
(Filed With SEC on October 29, 2019)
-
Employment Agreement, dated September 16, 2019, between the Company and Holli Cherevka
(Filed With SEC on September 20, 2019)
-
Stock Option Cancellation and Grant Agreement for Executive, dated August 20, 2019, between the Company and Daniel Stokely
(Filed With SEC on August 23, 2019)
-
Amendment to Employment Agreement, dated August 20, 2019, between the Company and Daniel Stokely
(Filed With SEC on August 23, 2019)
-
Employment Agreement, dated July 9, 2019, between the Company and Daniel Stokely
(Filed With SEC on July 10, 2019)
-
Form of Lock-Up Agreement
(Filed With SEC on June 17, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 17, 2019)
-
Placement Agency Agreement, dated June 17, 2019, by and among Ampio Pharmaceuticals, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc
(Filed With SEC on June 17, 2019)
-
Separation Agreement, dated as of June 13, 2019, between Ampio Pharmaceuticals, Inc. and Thomas E. Chilcott, III
(Filed With SEC on June 13, 2019)
-
Equity Distribution Agreement, dated as of April 12, 2019, by and between Canaccord Genuity LLC and Ampio Pharmaceuticals, Inc
(Filed With SEC on April 15, 2019)